Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Rita Conigliaro, Marzio Frazzoni, editors.
    Contents:
    Confocal laser endomicroscopy in GI tract
    OTSC system in all possible applications
    Radiofrequency ablation of pancreatic mass
    TEM and TAMIS for large rectal neoplasm
    Unusual applications of metal stents in gastrointestinal tract
    Endoscopic suturing systems
    Endoluminal therapy for treatment of gastroesophageal reflux disease
    The point on the POEM: comparison between different techniques and outcomes
    News in ESD
    ERCP in altered anatomy
    Endoscopic and surgical management of Zenker's diverticulum: new approaches
    Cholangioscopy systems: state of the art
    Esophageal motility testing: the present and the future
    The diagnostic yield of novel parameters in reflux monitoring.
    Digital Access Springer 2017
  • Article
    Franklin R.
    South Med J. 1978 Feb;71(2):141-3.
    There were 150 patients with mycologically proven vulvovaginal candidiasis in a randomized, non-cross-over study which compared seven-and 14-day treatment courses of clotrimazole vaginal tablets (Gyne-Lotrimin) with a 14-day treatment course of miconazole nitrate 2% vaginal cream (Monistat). Adequate data for analyses were obtained for 117 patients. When patients were reexamined four or more weeks after completion of therapy, success rates, based on clinical and mycologic criteria, were: 88% for patients treated with clotrimazole for seven days, 84% for clotrimazole 14-day treatment, and 78% for miconazole nitrate 14-day treatment. There were no drug-related adverse reactions. Thus a seven-day course of therapy with clotrimazole is effective as is a 14-day course of either clotrimazole or miconazole nitrate 2% for the treatment of Candida vaginitis. Statistical analysis revealed no significant differences among the clotrimazole seven-and 14-day treatment groups and the miconazole nitrate 14-day treatment group. The shorter period of administration required for this new antifungal agent should result in better patient compliance and an improved success rate in the rate in the treatment of this frequently encountered infection.
    Digital Access Access Options